EXPLORING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early recognition of illnesses is crucial for improving patient outcomes and reducing the impact of chronic conditions. Traditionally, disease screening has relied on symptomatic observations and destructive diagnostic methods. However, these approaches often fail to identify diseases in their early stages, when treatment is significantly effective